• 제목/요약/키워드: Neoplasm metastases

검색결과 106건 처리시간 0.032초

A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma

  • Jo, Sunmi;Shim, Hye Kyung
    • Radiation Oncology Journal
    • /
    • 제31권4호
    • /
    • pp.267-272
    • /
    • 2013
  • Although significant advances in the treatment of intrahepatic lesions, it is reported that the prognosis for patients with hepatocellular carcinoma (HCC) who have extrahepatic metastasis remains poor. We report a patient with lung, liver, brain, bone and subcutaneous metastasis from HCC who has survived more than 7 years maintaining relatively good performance status as a result of repeated therapies. A 55-year-old male patient with HCC underwent right lobectomy of the liver and cholecystectomy in September 2006. He received wedge resection for lung metastasis twice (July 2009, January 2011) and Gamma Knife stereotactic radiosurgery for brain metastasis (April 2011). Over the last 3 years, he has developed metastasis in subcutaneous tissues, muscle, and bone with pain. He has undergone 7 courses of radiotherapies for subcutaneous tissues, muscle, and bone metastasis and been prescribed sorafenib and he is still capable of all self-care.

폐내의 흉막폐아세포종 (Pleuropulmonary Blastoma in Lung)

  • 박일;이응배
    • Journal of Chest Surgery
    • /
    • 제39권9호
    • /
    • pp.722-724
    • /
    • 2006
  • 흉막폐아세포종은 소아에서 발생하는 아주 드문 흉강 내 원발성 종양으로 폐아세포종과는 다른 병리학적 소견을 가진다. 수술적 완전 절제가 우선적인 치료법이며, 빠른 진행 및 전이를 보이기 때문에 신보조항암요법, 보조항암요법 등의 다각적인 방법을 고려하여야 한다. 저자들은 수술적 절제 및 보조항암요법으로 치료한 흉막폐아세포종 1예를 보고한다.

Metastatic adenocarcinoma of the mandible

  • Hwang Eui-Hwan;Hwang Ji-Young;Lee Sang-Rae
    • Imaging Science in Dentistry
    • /
    • 제34권4호
    • /
    • pp.219-223
    • /
    • 2004
  • Metastases to the jawbones are found predominantly in the mandible and are rare in relation to the overall spectrum of oral malignancy. Analysis of the literature shows that the most frequent primary sites are the breast, lung, kidney, thyroid, and prostate. Adenocarcinoma of the mandible, whether primary or metastatic, are usually difficult to diagnose clinically. We report a case illustrating the clinical, radiographic, and histologic findings of a metastatic lung adenocarcinoma of the anterior mandible in a 58-year-old male.

  • PDF

원발성폐지방육종(Primary Pulmonary Liposarcoma)에 관한 수술치험 1예 (Surgery for Primary Pulmonary Liposarcoma)

  • 김수완;김진국;김관민;최용수;안긍환;심영목
    • Journal of Chest Surgery
    • /
    • 제37권11호
    • /
    • pp.942-945
    • /
    • 2004
  • 원발성폐지방육종은 극히 드문 질환일 뿐만 아니라, 국소재발이 빈번하고 발병 초기에 원격전이가 발생하여 예후가 불량한 질환이다. 지방육종의 치료를 위해서는 수술적인 절제가 우선적이나, 완전히 절제를 못하였을 경우 지방육종이 국소적으로 재발하게 되고 상당히 빠른 속도로 자라게 된다. 저자들은 원발성폐지방육종을 완전 절제하여 10개월 간 재발 및 전이가 없는 예를 경험하였기에 보고하는 바이다.

Primary Transitional Cell Carcinoma of the Renal Pelvis in a Dog

  • Park, Ju-yong;Kang, Min-Hee
    • 한국임상수의학회지
    • /
    • 제37권4호
    • /
    • pp.204-207
    • /
    • 2020
  • A 12-year-old dog was evaluated for depression and anorexia. The results of complete blood count and serum biochemistry were normal. Survey radiographs revealed markedly enlarged right kidney and abdominal ultrasound showed a renomegaly and hydronephrosis filled with mixed echogenic fluid. Primary renal tumor was suspected in this dog. Nephroureterectomy of the right kidney was performed, and no regional metastases have been identified. Transitional cell carcinoma (TCC) arising from renal pelvis accompanied hydronephrosis of the right kidney was diagnosed on histology. TCC usually affects trigone of the bladder, and renal origin of TCC is a very rare finding in dogs. This is the first case report to present the clinical features, diagnostic imaging findings and histopathological characteristics of a dog with TCC originating from the renal pelvis in Korea.

Massive lymphangiosarcoma in a dog: a case report

  • Seo, Min-Gyeong;Choi, Yeon-Woo;Jung, Dong-In;Lee, Hee Chun;Hong, Il-Hwa
    • 대한수의학회지
    • /
    • 제61권4호
    • /
    • pp.32.1-32.4
    • /
    • 2021
  • A 12-year-old neutered male Golden Retriever presented with a progressively enlarging mass in the submandibular region. Histopathological diagnosis confirmed lymphangiosarcoma with metastasis to the liver and spleen. The pleomorphic neoplastic endothelial cells of the tumor grow directly on bundles of dermal collagen, forming numerous clefts and interconnecting channels that are devoid of conspicuous hematic elements. As lymphangiosarcoma is an uncommon malignant neoplasm, the number of previously reported cases and information of the tumor is limited. The present report describes the clinical history and histopathological diagnosis of a progressive lymphangiosarcoma in the submandibular region with metastases in a dog.

A Case of Complete Resection of a Solid Pseudopapillary Tumor with Hepatic Metastasis

  • Hyoung Woo Kim;Jong-Chan Lee;Jongchan Lee;Jaihwan Kim;Jin-Hyeok Hwang
    • Journal of Digestive Cancer Research
    • /
    • 제4권1호
    • /
    • pp.29-31
    • /
    • 2016
  • Solid pseudopapillary tumor (SPT) of the pancreas is a rare neoplasm with low malignant potential, which has a good prognosis with more than 95% survival at 5 years. Only approximately 10% to 15% cases of SPTs are malignant. This report presents a case of a 38-year-old woman who developed malignant SPT of the pancreas with synchronous multiple hepatic metastases. She underwent a successfully complete surgical resection for multiple hepatic metastatic tumors in addition to primary tumor.

  • PDF

Prognostic Factors and Scoring Systems for Non-Small Cell Lung Cancer Patients Harboring Brain Metastases Treated with Gamma Knife Radiosurgery

  • Eom, Jung-Seop;Cho, Eun-Jung;Baek, Dong-Hoon;Lee, Kyung-Nam;Shin, Kyung-Hwa;Kim, Mi-Hyun;Lee, Kwang-Ha;Kim, Ki-Uk;Park, Hye-Kyung;Kim, Yun-Sung;Park, Soon-Kew;Cha, Seong-Heon;Lee, Min-Ki
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권1호
    • /
    • pp.15-23
    • /
    • 2012
  • Background: The survival of non-small cell lung cancer (NSCLC) patients with brain metastases is reported to be 3~6 months even with aggressive treatment. Some patients have very short survival after aggressive treatment and reliable prognostic scoring systems for patients with cancer have a strong correlation with outcome, often supporting decision making and treatment recommendations. Methods: A total of one hundred twenty two NSCLC patients with brain metastases who received gamma knife radiosurgery (GKRS) were analyzed. Survival analysis was calculated in all patients for thirteen available prognostic factors and four prognostic scoring systems: score index for radiosurgery (SIR), recursive partitioning analysis (RPA), graded prognostic assessment (GPA), and basic score for brain metastases (BSBM). Results: Age, Karnofsky performance status, largest brain lesion volume, systemic chemotherapy, primary tumor control, and medication of epidermal growth factor receptor tyrosine kinase inhibitor were statistically independent prognostic factors for survival. A multivariate model of SIR and RPA identified significant differences between each group of scores. We found that three-tiered indices such as SIR and RPA are more useful than four-tiered scoring systems (GPA and BSBM). Conclusion: There is little value of RPA class III (most unfavorable group) for the same results of 6-month and 1-year survival rate. Thus, SIR is the most useful index to sort out patients with poorer prognosis. Further prospective trials should be performed to develop a new molecular- and gene-based prognostic index model.

Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer

  • Won, Yong Kyun;Lee, Ja Young;Kang, Young Nam;Jang, Ji Sun;Kang, Jin-Hyoung;Jung, So-Lyoung;Sung, Soo Yoon;Jo, In Young;Park, Hee Hyun;Lee, Dong-Soo;Chang, Ji Hyun;Lee, Yun Hee;Kim, Yeon-Sil
    • Radiation Oncology Journal
    • /
    • 제33권3호
    • /
    • pp.207-216
    • /
    • 2015
  • Purpose: Stereotactic radiosurgery (SRS) has been introduced for small-sized single and oligo-metastases in the brain. The aim of this study is to assess treatment outcome, efficacy, and prognostic variables associated with survival and intracranial recurrence. Materials and Methods: This study retrospectively reviewed 123 targets in 64 patients with non-small cell lung cancer (NSCLC) treated with SRS between January 2006 and December 2012. Treatment responses were evaluated using magnetic resonance imaging. Overall survival (OS) and intracranial progression-free survival (IPFS) were determined. Results: The median follow-up was 13.9 months. The median OS and IPFS were 14.1 and 8.9 months, respectively. Fifty-seven patients died during the follow-up period. The 5-year local control rate was achieved in 85% of 108 evaluated targets. The 1- and 2-year OS rates were 55% and 28%, respectively. On univariate analysis, primary disease control (p < 0.001), the Eastern Cooperative Oncology Group (ECOG) performance status (0-1 vs. 2; p = 0.002), recursive partitioning analysis class (1 vs. 2; p = 0.001), and age (<65 vs. ${\geq}65$ years; p = 0.036) were significant predictive factors for OS. Primary disease control (p = 0.041) and ECOG status (p = 0.017) were the significant prognostic factors for IPFS. Four patients experienced radiation necrosis. Conclusion: SRS is a safe and effective local treatment for brain metastases in patients with NSCLC. Uncontrolled primary lung disease and ECOG status were significant predictors of OS and intracranial failure. SRS might be a tailored treatment option along with careful follow-up of the intracranial and primary lung disease status.

Quantitative Changes in Tumor-Associated M2 Macrophages Characterize Cholangiocarcinoma and their Association with Metastasis

  • Thanee, Malinee;Loilome, Watcharin;Techasen, Anchalee;Namwat, Nisana;Boonmars, Thidarut;Pairojkul, Chawalit;Yongvanit, Puangrat
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권7호
    • /
    • pp.3043-3050
    • /
    • 2015
  • The tumor microenvironment (TME) includes numerous non-neoplastic cells such as leukocytes and fibroblasts that surround the neoplasm and influence its growth. Tumor-associated macrophages (TAMs) and cancerassociated fibroblasts (CAFs) are documented as key players in facilitating cancer appearance and progression. Alteration of the macrophage (CD68, CD163) and fibroblast (${\alpha}-SMA$, FSP-1) cells in Opisthorchis viverrini (Ov) -induced cholangiocarcinoma (CCA) was here assessed using liver tissues from an established hamster model and from 43 human cases using immunohistochemistry. We further investigated whether M2-activated TAMs influence CCA cell migration ability by wound healing assay and Western blot analysis. Macrophages and fibroblasts change their phenotypes to M2-TAMs (CD68+, CD163+) and CAFs (${\alpha}-SMA+$, FSP-1+), respectively in the early stages of carcinogenesis. Interestingly, a high density of the M2-TAMs CCA in patients is significantly associated with the presence of extrahepatic metastases (p=0.021). Similarly, CD163+ CCA cells are correlated with metastases (p=0.002), and they may be representative of an epithelial-to-mesenchymal transition (EMT) with increased metastatic activity. We further showed that M2-TAM conditioned medium can induce CCA cell migration as well as increase N-cadherin expression (mesenchymal marker). The present work revealed that significant TME changes occur at an early stage of Ov-induced carcinogenesis and that M2-TAMs are key factors contributing to CCA metastasis, possibly via EMT processes.